Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, December 9 at 2:00 PM ET

Register Free →

This Award Notice opportunity from Florida was posted on July 22, 2025. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

MAKE FDA-APPROVED ANTICANCER DRUGS EFFECTIVE FOR THE MOST DI

Awarded
25C08State & Local

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

This award notice and contract, identified as 25C08, establishes an agreement between the Florida Department of Health and the University of Central Florida Board of Trustees. Funded through the Florida Cancer Innovation Fund, the project is led by Principal Investigator Jihe Zhao and focuses on enhancing the effectiveness of FDA-approved anticancer drugs for the most difficult-to-treat breast cancer patients by targeting a novel drug-resistant cancer gene through innovative drug-delivery technologies. The initiative aligns with the fund's goal of supporting emerging research trends and promising practices that serve as catalysts for further cancer research exploration. The agreement is governed by the Florida Department of Health Standard Contract, which mandates compliance with Florida state law and federal regulations, including HIPAA and the Pro-Children Act of 1994, while explicitly prohibiting the use of state funds for Diversity, Equity, and Inclusion programs. Under Amendment A1, the project has been granted a no-cost extension, shifting the performance end date from June 30, 2026, to December 31, 2026.

General Info

Florida Health and UCF research breast cancer drug delivery through December 31, 2026.

Contract Value

$510,656

NAICS

N/A

Place of Performance

FL, USA

Set-Aside

NONE

Award Issued Date

Contract End Date

December 31, 2026

Documents

3
PDF, High priority: read this firstamendment
High
PDF, High priority: read this firstrfp
High
PDF, Low prioritycontract-document
Low

Read all 3 documents

Every page of every file, in your free workspace.

Read the documents

AI Contract Breakdown

Uniform Contract Format

Contract not broken down yet

CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.

Ask CLEATUS

I've read this contract. Ask me anything.

Timeline

PhaseAwarded
Posted

Award Notice

Awarded

Contract was awarded

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyFlorida → Department Of Health
ContactsNo contacts available
OfficeN/A
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
The Florida Cancer Innovation Fund provides grant support for innovative cancer-related research efforts, including emerging research trends and promising practices, which can serve as a catalyst for further exploration. TITLE: MAKE FDA-APPROVED ANTICANCER DRUGS EFFECTIVE FOR THE MOST DIFFICULT-TO-TREAT BREAST CANCER PATIENTS BY TARGETING A NOVEL DRUG-RESISTANT CANCER GENE USING INNOVATIVE DRUG-DELIVERY TECHNOLOGIES PI: JIHE ZHAO

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS